
Safecure IPO GMP: Day 1 IPO Live Updates
Posted by : sachet | Wed Oct 29 2025

Click & Sign Up to Get Latest Updates on Safecure IPO
The Safecure IPO GMP is ₹21 as of 29th October 2025. It is a book-building IPO of ₹30.60 crore, comprising a fresh issue of 30,00,000 shares. The issue will be listed on BSE and SME on its tentative listing date, 6th November 2025. The face value of Safecure shares is ₹10 per share, and the IPO price is set at ₹102 per share. Retail investors can bid for a minimum of 2 lots of 2,400 shares, worth ₹2,44,800.
Safecure IPO Grey Market Premium
As of 29th October 2025, the GMP for the Safecure IPO stands at ₹0 per share. Thus, the estimated listing price would be ₹102. This indicates that the estimated listing gain in this IPO could be 0.00%. However, GMP details are subject to change based on market conditions and fluctuations. Explore the table for GMP updates on the Safecure IPO.
| GMP Date | IPO Price | GMP | Estimated Listing Price | Estimated Listing Gains |
| 29-10-2025 | ₹102.00 | ₹21.00 | ₹123.00 | 20.59% |
| 28-10-2025 | ₹102.00 | ₹21.00 | ₹123.00 | 20.59% |
| 27-10-2025 | ₹102.00 | ₹0.00 | ₹102.00 | 0.00% |
| 26-10-2025 | ₹102.00 | ₹0.00 | ₹102.00 | 0.00% |
| 25-10-2025 | ₹102.00 | ₹0.00 | ₹102.00 | 0.00% |
Safecure IPO Details
| IPO Open Date | 29th October 2025 |
| IPO Close Date | 31st October 2025 |
| IPO Allotment Date | 3rd November 2025 |
| Refund Initiation | 4th November 2025 |
| Face Value | ₹10 per share |
| Issue Size | ₹102 per share |
| Lot Size | 1,200 share |
| Issue Size | 30,00,000 shares(aggregating up to ₹30.60 Cr) |
| Price Band | ₹102 per share |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE and NSE |
| Listing Date | 10th November 2025 |
Explanation
Safecure IPO: Safecure Limited has announced the issue price of ₹102 per share. With this IPO, the company allows retail investors to bid for two lots of 2,400 shares worth ₹2,44,800. The face value of Safecure Limited shares is ₹10 per share. The shares of Safecure Limited will be listed on BSE and SME on its tentative listing day, 6th November 2025. Scroll down to view GMP updates and reviews of the Safecure IPO.
Objectives of the Safecure IPO
The primary aim of the Safecure IPO is to raise ₹30.60 crore. On the other hand, the Safecure IPO has decided to utilise these funds in different ways.
- To repay in full of certain borrowings availed by the company.
- To meet general corporate purposes
- To fndworking capital requirement of the company
Safecure IPO Registrar
MUFG Intime India Private Limited will be the registrar responsible for managing allotment and refund procedures. For any queries regarding the Safecure IPO GMP, allotment, or refund, you can contact MUFG Intime India Private Limited at ipo.helpdesk@linkintime.co.in or +91-22-49186270.
Safecure IPO Review

The Safecure IPO has gained neutral ratings from industry experts, brokers, and institutional investors. Safecure Limited’s revenue increased by 16% from ₹63,06 crores in March 2024 to ₹73.27 crores in March 2025. Moreover, the company’s PAT increased by 8% from ₹5.69 crores to ₹6.16 crores. Investors can analyse other relevant factors and make a decision accordingly.
Most analysts recommend applying for this IPO to diversify your investment portfolio. However, we’re waiting for further ratings to gain a better understanding and will continue to post them to deliver real-time insights. Until then, you can review the company’s technical analysis to decide whether to apply for the Safecure IPO.
Technical Analysis
Several technical indicators are available to assess a company’s potential to deliver returns. Use the parameters mentioned below to analyse the technical aspects of the Safecure IPO.
| Key Indicators | Value |
| PE Ratio (Price-to-Earnings) | 11.66 |
| EPS (Earnings Per Share) | 8.75 |
| RoNW | 28.48% |
| ROCE | 22.48% |
| ROE | 28.86% |
| EBITDA Margin | 14.60% |
| Price to Book Value | 4.79 |
| Market Capitalisation | ₹102.41 Cr |
The P/E ratio of Safecure Limited’s shares is 11.66, and its Earnings Per Share (EPS) is 8.75. Thus, the Safecure Limited IPO can deliver gains on its tentative listing day.
Note: The data, as mentioned above, is taken from authentic sources and highlights pre-issue information. The PE ratio and EPS of Mittal Solutions Limited are subject to change following the IPO. Refer to the table below for post-issue updates on these two metrics.
Download the Univest iOS App or the Univest Android App to get daily stock recommendations and insightful research pieces!
FAQs on Safecure IPO
What is the GMP of the Safecure IPO?
Ans. As of 29th October 2025, the Safecure (Grey Market Premium) stands at ₹21. This suggests that the estimated listing price could be 20.59% of the share price.
What is the issue price of the Safecure IPO?
Ans. The Safecure IPO price range is ₹102 per share. Retail investors can apply for a minimum of 2 lots, each consisting of 2,400 shares, worth ₹2,44,800. Moreover, HNIs are required to bid for a minimum of 2 lots (3,600 shares) worth ₹367,200.
Who is the registrar of the Safecure IPO?
As per the recent updates, MUFG Intime India Private Limited will be the registrar responsible for managing allotment and refund procedures. For any queries regarding Safecure IPO GMP, allotment, and refund, you can contact MUFG Intime India Private Limited at ipo.helpdesk@linkintime.co.in or +91-22-49186270.
Disclaimer: The above information is compiled from authentic sources and is just for informational purposes. To have detailed information about the Safecure IPO, download the Safecure IPO RHP and Safecure IPO DRHP. Conduct thorough research before investing in IPOs to minimise the risk of significant losses. You can also consult your financial advisor.
Recent Articles
Top 10 Penny Stocks in India | Penny Stocks to Buy in 2025
Best Stocks to Buy Today: Explore Best Stocks With Expected Trends
Milky Mist Dairy Foods IPO Details: Everything You Should Know about
Karbonsteel Engineering IPO GMP & Review: Should You Apply or Avoid?
Taurian MPS IPO GMP & Review: Should You Apply or Avoid?
Shringar House of Mangalsutra IPO GMP & Review: Apply or Avoid?
Dev Accelerator IPO GMP & Review: Apply or Avoid?
Related Posts
Blue Dart Express Q2 Results 2025 Highlights: Net Profit Rises by 29.50% & Revenue Up 6.96% YoY
Adani Green Energy Q2 Results 2025 Highlights: Net Profit Surged by 111.23% & Revenue Up 0.10% YoY
MRF Share Price Grabs Bullish Momentum: What’s Next Target?
Happiest Minds Technologies Q2 Results 2025 Highlights: Net Profit Rises by 9.09% & Revenue Up 9.96% YoY
Safecure IPO Subscription Day 1: Check Online

